Skip to main content
OpenTrials
Completed

NCT Number: NCT04166175

High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure

comparison between the effect of lateral sphincterotomy against high dose botox injection in chronic anal fissure the outcome was healing time, recurrence continence relapse pain pruritus

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zagazig Faculty of Medicine

Zagazig, Sharqya, 44519, Egypt

About this study

This randomized comparative clinical trial was carried out over 2 year in the period between January 2018 and December 2019 on total number of 96 patients suffering chronic anal fissure the participants were randomly allocated into two groups each 48 patients ; group (1) the botulinum ( Botox) group, they were subjected to 80 IU Botox injection as an intervention for treatment of chronic anal sphincter, and group 2 the sphincterotomy group, underwent internal sphincterotomy as a surgical intervention for treatment of chronic anal fissure.

The study was approved by the institutional review board and the local ethical committee of our university hospital The condition of the current study is chronic anal fissure defined as the presence of anterior or posterior chronic anal wound with skin tag at its lower end and hypertrophied anal papilla at its upper end with induration around its edges in patients complaining of anal pain, constipation, and/or fresh anal bleeding for at least two months.

Randomization was achieved using computer generated cards. Inclusion criteria; patients suffering chronic anal fissure aged above 16 years old Exclusion criteria; those with previous anal surgery, complicated anal fissure, unfit for surgery, specific disease as Crohn's disease and ulcerative colitis, malignancy, anal fistula or abscess those with systemic disease requiring treatment with calcium channel blockers and /or nitrates Patients of both groups were subjected to thorough history taking, clinical examination, digital rectal examination and anorectal manometry for diagnosis of chronic anal fissure and exclusion of any other anal condition and incontinence, patient signed an informed written consent, routine preoperative investigations performed as usual.

Interventions;

  • Botulinum toxin (Botox) injection; was performed under general anesthesia in the lithotomy position, where 80 IU of Botox was injected in four positions each 20 IU namely in 5, 7, 11, and 1 O'clock positions in the intersphincteric space not deeper than the midpoint of the anal canal.
  • Lateral internal sphincterotomy; was performed under general anesthesia where the lower part of the internal sphincter was cut by electrocautery on the left lateral position to an extent not beyond the proximal end of the fissure, the sentinel pile was also removed.

After the procedure patients were advised for bulking agents, stool softener, and sitz baths The follow up was carried out in the outpatient clinic by the attending surgeon (not a study participant) after 1 week then 1, 2, 3, 6, 9 and 12 months post-procedure.

The primary outcome of the current study is complete healing of the chronic anal fissure, recurrence in the follow up time, and development of incontinence, incontinence is described as in (the Cleveland Clinic Florida-Fecal Incontinence (CCF-FI) scoring system), which contains 5 questions on solid and liquid stool leakage, gas leakage, pad use, and lifestyle restriction. the secondary outcome is postoperative or post-injection pain measured by visual analogue scale (VAS) and the time taken for complete healing of fissure (defined as complete epithelialization of the fissure).

Demographic data, presentation data, follow up data including primary and secondary outcome all collected and analyzed properly using t test, chi square test, and Z test in SPSS program 22 version.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients suffering chronic anal fissure aged above 16 years old

Exclusion criteria

  • those with previous anal surgery,
  • complicated anal fissure,
  • unfit for surgery,
  • specific disease as Crohn's disease and ulcerative colitis,
  • malignancy,
  • anal fistula or abscess
  • those with systemic disease requiring treatment with calcium channel blockers and /or nitrates

Treatment and study plan

botox injection in intersphincteric space

Procedure

injection of 80 IU of botox in the intersphincteric space in 5,7,11 and 1 O'clock position

lateral internal sphincterotomy

Procedure

lateral internal sphincterotomy under GA in lithotomy position

Primary outcomes

  1. complete healing of fissure

    Time frame: 2 months

    complete epithelialization of the floor of the chronic anal wound achieved through clinical examination at follow up visits

  2. loss of anal continence

    Time frame: 1 week

    inability to control stool or flatus measured by modified wexner score questionaire

  3. recurrence

    Time frame: 1 year

    the anal fissure reformed again after complete healing measured by clinical examination

Secondary outcomes

  1. time taken for complete healing

    Time frame: 1 year

    time taken for complete epithelialization of the anal wound measured by clinical examination

  2. post operative pain

    Time frame: 1 month

    pain in the postoperative time measured by visual analogue scale

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Official study title

Treatment of Chronic Anal Fissure, Lateral Internal Sphincterotomy Versus Local Injection of High Dose Botulinum Toxin: A Randomized Clinical Trial

Acronym: professor

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Nov 18, 2019
Registry last updated
Nov 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.